Gastroenterology
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Global pharma market insights for gastroenterology: track drug development, regulatory approvals, and M&A for IBD, liver disease, and GI oncology.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Gastroenterology hub for NMPA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Ironwood Pharmaceuticals Survey Reveals Critical Gaps in Short Bowel Syndrome TPN Treatment at DDW 2026
SynbioTech's L. plantarum FS4722 Shows Promise for Hyperuricemia Prevention in Preclinical Studies
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.